Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven M Larson

Showing results (91-100 of 300) with videos related to

Pageof 30
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|January 27, 2005
Intercellular transfer of P-glycoprotein mediates acquired multidrug resistance in tumor cellsAndre Levchenko, Bipin M Mehta, Xinle Niu, et al.
Nuclear Medicine and Biology|February 2, 2002
Ga-66 labeled somatostatin analogue DOTA-DPhe1-Tyr3-octreotide as a potential agent for positron emission tomography imaging and receptor mediated internal radiotherapy of somatostatin receptor positive tumorsOmer Ugur, Paresh J Kothari, Ronald D Finn, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 6, 2007
Deep-inspiration breath-hold PET/CT of the thoraxSadek A Nehmeh, Yusuf E Erdi, Gustavo S P Meirelles, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 2, 2002
A retrospective review of the effectiveness of recombinant human TSH as a preparation for radioiodine thyroid remnant ablationRichard J Robbins, Steven M Larson, Naina Sinha, et al.
Molecular Imaging and Biology|April 15, 2011
Initial results with (11)C-acetate positron emission tomography/computed tomography (PET/CT) in the staging of urinary bladder cancerHeiko Schöder, Seng C Ong, Victor E Reuter, et al.
Bioconjugate Chemistry|October 24, 2013
N-acetylgalactosamino dendrons as clearing agents to enhance liver targeting of model antibody-fusion proteinBarney Yoo, Sarah M Cheal, Geralda Torchon, et al.
Neuro-Oncology|September 7, 2012
A novel ligand delivery system to non-invasively visualize and therapeutically exploit the IL13Rα2 tumor-restricted biomarkerVan Nguyen, Jesse M Conyers, Dongqin Zhu, et al.
Cell Reports. Medicine|March 28, 2025
Radioimmunotherapy for peritoneal carcinomatosis: Preclinical proof of concept to clinical translationNicole Aguirre, Darren R Veach, Andrea Cercek, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2005
Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin's lymphomaHeiko Schöder, Ariela Noy, Mithat Gönen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 6, 2007
Prediction of absorbed dose to normal organs in thyroid cancer patients treated with 131I by use of 124I PET and 3-dimensional internal dosimetry softwareKatherine S Kolbert, Keith S Pentlow, Joel R Pearson, et al.
Pageof 30

Showing results (91-100 of 300) with videos related to

Sort By:
Pageof 30
Proceedings of the National Academy of Sciences of the United States of America|January 27, 2005
Intercellular transfer of P-glycoprotein mediates acquired multidrug resistance in tumor cellsAndre Levchenko, Bipin M Mehta, Xinle Niu, et al.
Nuclear Medicine and Biology|February 2, 2002
Ga-66 labeled somatostatin analogue DOTA-DPhe1-Tyr3-octreotide as a potential agent for positron emission tomography imaging and receptor mediated internal radiotherapy of somatostatin receptor positive tumorsOmer Ugur, Paresh J Kothari, Ronald D Finn, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 6, 2007
Deep-inspiration breath-hold PET/CT of the thoraxSadek A Nehmeh, Yusuf E Erdi, Gustavo S P Meirelles, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 2, 2002
A retrospective review of the effectiveness of recombinant human TSH as a preparation for radioiodine thyroid remnant ablationRichard J Robbins, Steven M Larson, Naina Sinha, et al.
Molecular Imaging and Biology|April 15, 2011
Initial results with (11)C-acetate positron emission tomography/computed tomography (PET/CT) in the staging of urinary bladder cancerHeiko Schöder, Seng C Ong, Victor E Reuter, et al.
Bioconjugate Chemistry|October 24, 2013
N-acetylgalactosamino dendrons as clearing agents to enhance liver targeting of model antibody-fusion proteinBarney Yoo, Sarah M Cheal, Geralda Torchon, et al.
Neuro-Oncology|September 7, 2012
A novel ligand delivery system to non-invasively visualize and therapeutically exploit the IL13Rα2 tumor-restricted biomarkerVan Nguyen, Jesse M Conyers, Dongqin Zhu, et al.
Cell Reports. Medicine|March 28, 2025
Radioimmunotherapy for peritoneal carcinomatosis: Preclinical proof of concept to clinical translationNicole Aguirre, Darren R Veach, Andrea Cercek, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2005
Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin's lymphomaHeiko Schöder, Ariela Noy, Mithat Gönen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 6, 2007
Prediction of absorbed dose to normal organs in thyroid cancer patients treated with 131I by use of 124I PET and 3-dimensional internal dosimetry softwareKatherine S Kolbert, Keith S Pentlow, Joel R Pearson, et al.
Pageof 30